Dr. Henry Sun

  • 768 view(s)

Dr. Henry Sun

  • 768 view(s)

About Dr. Henry Sun

In the past 10 years, Dr. Sun leads his group successfully registered over 20 new drugs in 32 countries, and made a historical milestone to develop a multi-herbal drug product to its clinical phase III stage in the United States. His view of Tasly is to bring this top China based Pharma to become a global company in the next 10 years. His current interests are the development of innovative drugs, research in regulatory policy and clinical pharmacology, and promotion of translational medicine.

Dr. Sun is also a professor and department chairman at the School of Pharmaceutical Science and Technology, Tianjin University, China; and a special professor at the School of Medicine of Nottingham University, Nottingham, UK.

Dr. Henry He Sun is the Vice President of Tasly Holding Group, Co. Ltd., CEO of Tasly Science & Technology Innovation Group, and Co-founder and CEO of Tasly Pharmaceuticals, Inc. of Rockville, Maryland. He graduated from Shanghai Medical University in 1982, and received his Ph.D. in Clinical Pharmacology from the University of Connecticut in 1993. Dr. Sun then joined the FDA leading the pharmacometrics programs in Divisions 3 and then 2 of Office of Clinical Pharmacology. Dr. Sun started to serve on his current position after 13 years of Federal Services.

 

Photo Gallery

Bitnami